Skip to content
CEpartner4U
  • Welcome
  • About us
    • Team
    • Jobs
  • Services
    • AR/EC Rep
    • Regulatory affairs
    • Quality system
    • CE/QMS Entry Packages©
    • Clinical evaluation
    • Training
  • UKCApartner4U
  • Information
    • F.A.Q. AR/EC Rep
    • Links
  • Library
  • News
  • Network
  • Contact

About:m.vandervoort

Posts by m.vandervoort :

  • EC published final report of Study on implementation of Article 17 of MDR on medical devices on the EU market, 10 April 2024 in Uncategorized
  • MDCG publishes 2024-03 on Guidance on contents CIP, 12 March 2024 in Uncategorized
  • IMDRF publishes guiding principles to support medical device health equity, 6 February 2024 in Uncategorized
  • EC proposes to extend transition periods for certain IVDs, gradual roll-out of Eudamed and an information obligation in case of interruption of supply, 23 January 2024 in Uncategorized
  • MDCG 2023-7 on Exemptions MDR Clinical Investigation published, 21 December 2023 in Uncategorized
  • MDCG 2021-27 Revision 1 published, 19 December 2023 in Uncategorized
  • MDCG 2019-7 Rev.1 published on the PRRC, 19 December 2023 in Uncategorized
  • MDCG 2023-5 and MDCG-6 guidances published on Annex XVI products, 14 December 2023 in Uncategorized
  • MDCG 2021-6 MDR – Questions & Answers regarding clinical investigation – Rev.1, 12 December 2023 in Uncategorized
  • 2023/2713: Regulation on designating European Union reference laboratories in the field of in vitro diagnostic medical devices, 6 December 2023 in Uncategorized
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 12
  • »

Stay informed

Please check your inbox or spam box to confirm

Copyright 2026 CEpartner4U | Esdoornlaan 13 | 3951 DB Maarn | The Netherlands | +31.6.516.536.26 | office@cepartner4u.com
  • enEnglish